A 7-year-old girl is brought to the pediatric clinic by her mother who reports multiple episodes of behavioral arrest lasting 10–15 seconds throughout the day. During these episodes, the child stares blankly, exhibits mild eye fluttering, and resumes normal activity immediately without confusion. The EEG shows the pattern marked **A** in the diagram — a generalized, bilaterally synchronous, symmetric discharge at 3 Hz on a normal background. Hyperventilation during EEG provokes additional bursts. Which of the following drugs is the most appropriate first-line agent for this condition?

Explanation

## Why Ethosuximide is right The clinical presentation (brief staring spells, behavioral arrest, no postictal confusion) combined with the classic EEG finding of generalized 3 Hz spike-and-wave discharges on a normal background is pathognomonic for childhood absence epilepsy (CAE). The 3 Hz spike-and-wave pattern marked **A** is generated by abnormal thalamocortical oscillations driven by T-type calcium channels in thalamic reticular neurons. Ethosuximide is the first-line agent for CAE because it selectively blocks these T-type calcium channels, directly addressing the pathophysiological mechanism. The landmark NEJM 2010 trial demonstrated that ethosuximide is superior to valproate in both efficacy and cognitive side-effect profile for absence seizures, making it the preferred initial choice (Nelson Pediatrics 21e Ch 611; Harrison 21e Ch 423). ## Why each distractor is wrong - **Valproate**: Although equally effective for absence seizures, valproate causes more attentional and cognitive adverse effects than ethosuximide and is reserved for cases where generalized tonic-clonic seizures coexist. It is not first-line for pure CAE. - **Carbamazepine**: This is contraindicated in absence epilepsy; carbamazepine and other sodium channel blockers (phenytoin, oxcarbazepine) actually worsen absence seizures and may paradoxically increase seizure frequency. - **Lamotrigine**: This is a third-line agent for CAE, used only when first- and second-line drugs have failed or are contraindicated. It is not appropriate as initial monotherapy. **High-Yield:** Generalized 3 Hz spike-wave + staring spells = CAE; ethosuximide first-line (blocks thalamic T-type Ca²⁺ channels); carbamazepine worsens absence. [cite: Nelson Pediatrics 21e Ch 611; Harrison 21e Ch 423]